Partager

Latest Documents


  • 29-November-2018

    English, PDF, 757kb

    How resilient were OECD health care systems during the “refugee crisis”? - OECD Migration Policy Debates

    This edition of Migration Policy Debates reviews current challenges and good practices for making OECD health systems more resilient in the face of a refugee crisis, drawing from a debate at a joint OECD, the World Bank and the Center for Mediterranean Integration conference on “Human Resources for Health (HRH): Integration of Refugees into Host Community Health Systems”.

    Related Documents
  • 29-November-2018

    English

    Pharmaceutical Innovation and Access to Medicines

    This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing. It then highlights current issues for policy makers, such as the increasing prices of new medicines; concerns about the value of spending in some therapeutic areas; challenges in anticipating the arrival of very effective medicines for highly prevalent diseases; sharp price increases in off-patent products; and the apparent misalignment of current incentives for the development of treatments for certain conditions. The report also describes the role of the biopharmaceutical industry in OECD economies, examines the process of pharmaceutical R&D and its financing, and looks at the risks, costs and return from R&D investment for the industry. Examining trends in the industry over time, it shows that productivity of R&D expenditure has declined; that the duration of market exclusivity has remained relatively stable; that new medicines are increasingly being developed for small patient populations; and that the industry as a whole has remained highly profitable for investors. Lastly, the report presents a range of policy options for consideration by policy makers, to support the development of effective and co-ordinated responses to the identified challenges.
  • 28-November-2018

    English

    Mental Health

    Mental disorders account for one of the largest and fastest growing categories of the burden of disease worldwide. Mental ill-health can have devastating effects on individuals, families and communities, with one in every two people experiencing a mental illness in their lifetime. As many as 80% of those with a common mental disorder, and up to 50% of those with a severe mental disorder, do not seek or receive treatment.

  • 26-November-2018

    English

    Waiting Times

    Over the past decade, many OECD countries have introduced new policies to tackle excessive waiting times for elective treatments with some success. However, in the wake of the recent economic downturn and severe pressures on public budgets, waiting times may rise again, and it is important to understand which policies work.

  • 22-November-2018

    English, PDF, 2,328kb

    Health at a Glance: Europe 2018 - Chartset

    Access key results from "Health at a Glance: Europe 2018" in this chartset.

    Related Documents
  • 22-novembre-2018

    Français, PDF, 1,202kb

    Panorama de la santé : Europe 2018 - Chartset

    Présentation en français sur les résultats clés issus du Panorama de la santé : Europe 2018.

    Documents connexes
  • 22-November-2018

    English

    Country Health Profiles 2017

    The Country Health Profiles are an important step in the European Commission’s two-year State of Health in the EU cycle and are the result of joint work between the OECD and the European Observatory on Health Systems and Policies. The concise, policy relevant profiles are based on a transparent, consistent methodology, using both quantitative and qualitative data, yet flexibly adapted to the context of each EU Member State.

    Related Documents
  • 22-November-2018

    English

    Health at a Glance: Europe 2018 - State of Health in the EU Cycle

    Health at a Glance: Europe 2018 presents comparative analyses of the health status of EU citizens and the performance of the health systems of the 28 EU Member States, 5 candidate countries and 3 EFTA countries. It is the first step in the State of Health in the EU cycle of knowledge brokering. This publication has two parts. Part I comprises two thematic chapters, the first focusing on the need for concerted efforts to promote better mental health, the second outlining possible strategies for reducing wasteful spending in health. In Part II, the most recent trends in key indicators of health status, risk factors and health spending are presented, together with a discussion of progress in improving the effectiveness, accessibility and resilience of European health systems.
  • 7-November-2018

    English

    Stemming the Superbug Tide - Just A Few Dollars More

    Antimicrobial resistance (AMR) is a large and growing problem with the potential for enormous health and economic consequences, globally. As such, AMR has become a central issue at the top of the public health agenda of OECD countries and beyond. In this report, OECD used advanced techniques, including machine learning, ensemble modelling and a microsimulation model, to provide support for policy action in the human health sector. AMR rates are high and are projected to grow further, particularly for second- and third-line antibiotics, and if no effective action is taken this is forecasted to produce a significant health and economic burden in OECD and EU28 countries. This burden can be addressed by implementing effective public health initiatives. This report reviews policies currently in place in high-income countries and identifies a set of ‘best buys’ to tackle AMR that, if scaled up at the national level, would provide an affordable and cost-effective instrument in the fight against AMR.
  • 7-November-2018

    English, PDF, 2,366kb

    Stemming the Superbug Tide - Policy Brief

    This Policy Brief gives an insight to key messages and various highlights from the new OECD report "Stemming the Superbug Tide: Just a Few Dollars More", which analyses the impact of antimicrobial resistance (AMR). The report, based on new forecasts of the growth in resistance to 2050, outlines how countries can tackle AMR and significantly reduce the personal and economic costs.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>